02:23 AM EDT, 05/07/2026 (MT Newswires) -- Zealand Pharma (ZEAL.CO) plans to repurchase shares worth up to 1.3 billion Danish kroner beginning Thursday, according to a same-day release.

The Danish biotechnology group appointed Danske Bank as lead manager for the buyback, which will run until Oct. 31. The program is intended to meet obligations related to share-based incentive programs and reduce the company's share capital.

Zealand Pharma said it may repurchase up to 7,152,557 shares on Nasdaq Copenhagen.

Ämnen i artikeln

Zealand Pharma

Senast

356,90

1 dag %

13,23%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån